JP2005534648A5 - - Google Patents

Download PDF

Info

Publication number
JP2005534648A5
JP2005534648A5 JP2004510702A JP2004510702A JP2005534648A5 JP 2005534648 A5 JP2005534648 A5 JP 2005534648A5 JP 2004510702 A JP2004510702 A JP 2004510702A JP 2004510702 A JP2004510702 A JP 2004510702A JP 2005534648 A5 JP2005534648 A5 JP 2005534648A5
Authority
JP
Japan
Prior art keywords
flt
agent
medicament
agonist
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004510702A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005534648A (ja
JP5111729B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/017591 external-priority patent/WO2003103581A2/en
Publication of JP2005534648A publication Critical patent/JP2005534648A/ja
Publication of JP2005534648A5 publication Critical patent/JP2005534648A5/ja
Application granted granted Critical
Publication of JP5111729B2 publication Critical patent/JP5111729B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004510702A 2002-06-05 2003-06-05 肝成長及び肝保護のための組成物と方法 Expired - Fee Related JP5111729B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38663702P 2002-06-05 2002-06-05
US60/386,637 2002-06-05
PCT/US2003/017591 WO2003103581A2 (en) 2002-06-05 2003-06-05 Compositions and methods for liver growth and liver protection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010038622A Division JP2010159266A (ja) 2002-06-05 2010-02-24 肝成長及び肝保護のための組成物と方法

Publications (3)

Publication Number Publication Date
JP2005534648A JP2005534648A (ja) 2005-11-17
JP2005534648A5 true JP2005534648A5 (https=) 2006-07-20
JP5111729B2 JP5111729B2 (ja) 2013-01-09

Family

ID=29736189

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004510702A Expired - Fee Related JP5111729B2 (ja) 2002-06-05 2003-06-05 肝成長及び肝保護のための組成物と方法
JP2010038622A Withdrawn JP2010159266A (ja) 2002-06-05 2010-02-24 肝成長及び肝保護のための組成物と方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010038622A Withdrawn JP2010159266A (ja) 2002-06-05 2010-02-24 肝成長及び肝保護のための組成物と方法

Country Status (7)

Country Link
US (2) US7700571B2 (https=)
EP (2) EP2430923A1 (https=)
JP (2) JP5111729B2 (https=)
AU (1) AU2003251397B2 (https=)
CA (1) CA2486270C (https=)
IL (2) IL165392A0 (https=)
WO (1) WO2003103581A2 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001266696A1 (en) 2000-06-02 2001-12-11 Bracco Research Usa Compounds for targeting endothelial cells
US8263739B2 (en) 2000-06-02 2012-09-11 Bracco Suisse Sa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US20050100963A1 (en) 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
JP5111729B2 (ja) 2002-06-05 2013-01-09 ジェネンテック， インコーポレイテッド 肝成長及び肝保護のための組成物と方法
ATE548447T1 (de) * 2004-01-14 2012-03-15 Novahep Ab Menschlicher hepatische vorläuferzellen und verfahren zur verwendung davon
US8070703B2 (en) * 2004-03-10 2011-12-06 Vision Quest Industries Incorporated Electrically stimulating orthotic device and segmented liner
WO2006014678A2 (en) 2004-07-20 2006-02-09 Genentech, Inc. Compositions and methods of using angiopoietin-like 4 protein
EP2447281B1 (en) 2005-03-24 2015-12-16 ThromboGenics N.V. Novel anti-PLGF antibody
EP1866414B9 (en) 2005-03-31 2012-10-03 Calando Pharmaceuticals, Inc. Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
EP1904095B1 (en) 2005-06-30 2013-05-29 VIB, vzw Treatment of liver cirrhosis and its complications
NZ568809A (en) 2005-12-22 2011-08-26 Genentech Inc Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents
AU2007230580A1 (en) * 2006-03-27 2007-10-04 Genentech, Inc. Methods for treating kidney disorders
US8685730B2 (en) * 2006-05-02 2014-04-01 Wisconsin Alumni Research Foundation Methods and devices for differentiating pluripotent stem cells into cells of the pancreatic lineage
CN101250498B (zh) * 2008-04-07 2010-06-09 南通大学附属医院 用载肝细胞生长因子聚乳酸-o-羧甲基壳聚糖纳米粒子的肝细胞培养方法
CA2736929C (en) 2008-10-02 2019-02-26 Life Sciences Research Partners Vzw Inhibition of plgf to treat philadelphia chromosome positive leukemia
ES2788300T3 (es) * 2010-11-09 2020-10-21 Univ Cornell Regeneración hepática
ES2424476T3 (es) * 2011-03-31 2013-10-02 Bioalliance Pharma Nanopartículas cargadas con fármaco antitumoral quimioterápico
WO2013033513A1 (en) 2011-08-31 2013-03-07 University Of Georgia Research Foundation, Inc. Apoptosis-targeting nanoparticles
ES2628321T3 (es) 2011-12-01 2017-08-02 Thrombogenics N.V. Mejora del resultado de una trabeculectomía
EP2814496B1 (en) 2012-02-17 2018-04-11 University Of Georgia Research Foundation, Inc. Nanoparticles for mitochondrial trafficking of agents
WO2015138992A1 (en) 2014-03-14 2015-09-17 University Of Georgia Research Foundation, Inc. Mitochondrial delivery of 3-bromopyruvate
KR102461927B1 (ko) * 2016-02-17 2022-10-31 차의과학대학교 산학협력단 이식용 줄기세포 및 이를 포함하는 혈관신생의 유도 또는 촉진을 위한 이식용 약학 조성물
CN114224893B (zh) * 2022-01-25 2023-06-06 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 喹唑啉衍生物在制备防治砷致肝损伤药物中的用途
CN116869986B (zh) * 2023-07-13 2025-12-02 南方医科大学 β-羟基丁酸在制备促进肝细胞增殖和肝脏再生产品方面的应用
TWI909652B (zh) 2023-08-31 2025-12-21 日商肽夢想股份有限公司 具有ｖｅｇｆｒ－２促效劑活性的肽複合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5217999A (en) 1987-12-24 1993-06-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Styryl compounds which inhibit EGF receptor protein tyrosine kinase
DE69105495T2 (de) 1990-04-02 1995-04-06 Pfizer Benzylphosphonsäure-tyrosinkinaseinhibitoren.
US5302606A (en) 1990-04-16 1994-04-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
EP0586608A1 (en) 1991-05-29 1994-03-16 Pfizer Inc. Tricyclic polyhydroxylic tyrosine kinase inhibitors
US5227158A (en) 1991-06-10 1993-07-13 Genentech, Inc. Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon
AU661533B2 (en) 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
WO1994003427A1 (en) 1992-08-06 1994-02-17 Warner-Lambert Company 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
US6107046A (en) 1992-10-09 2000-08-22 Orion Corporation Antibodies to Flt4, a receptor tyrosine kinase and uses thereof
US5330992A (en) 1992-10-23 1994-07-19 Sterling Winthrop Inc. 1-cyclopropyl-4-pyridyl-quinolinones
GB9226855D0 (en) 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation
US6020473A (en) 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
DE69628652T3 (de) * 1995-09-08 2012-05-03 Genentech, Inc. Vegf-verwandtes protein
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
ES2265931T3 (es) 1999-04-16 2007-03-01 Genentech, Inc. Variantes del factor de crecimiento celular endotelial vascular (vegf) y sus usos.
US6475796B1 (en) * 1999-05-20 2002-11-05 Scios, Inc. Vascular endothelial growth factor variants
US20020164310A1 (en) * 2001-03-02 2002-11-07 Mgvs Ltd. Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
US6659223B2 (en) * 2001-10-05 2003-12-09 Collins & Aikman Products Co. Sound attenuating material for use within vehicles and methods of making same
JP5111729B2 (ja) * 2002-06-05 2013-01-09 ジェネンテック， インコーポレイテッド 肝成長及び肝保護のための組成物と方法

Similar Documents

Publication Publication Date Title
JP2005534648A5 (https=)
Shariat et al. Adenovirus-mediated transfer of inducible caspases: a novel “death switch” gene therapeutic approach to prostate cancer
Oupický et al. Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo
Gonzalez-Barrios et al. Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats
Eliaz et al. Robust and prolonged gene expression from injectable polymeric implants
Trinh et al. Pax-6 activates endogenous proglucagon gene expression in the rodent gastrointestinal epithelium
Duan et al. Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C
CA2354029C (en) Gene therapy for cardiomyopathy
Hecker et al. Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system
JPWO2001026694A1 (ja) 心筋症遺伝子治療
Wang et al. Construction of exosome-loaded LL-37 and its protection against zika virus infection
JP4219335B2 (ja) インターフェロンβのような分泌タンパク質をコードする遺伝子を使用する治療のための方法および組成物
US6696423B1 (en) Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
WO1997015668A2 (en) Methods and compositions comprising glut-2 and glut-2 chimeras
Jiang et al. Hypoxic response elements control expression of human vascular endothelial growth factor165 genes transferred to ischemia myocardium in vivo and in vitro
CN108079316A (zh) 干扰fxr表达试剂在制备抗肝纤维化药物中的应用
EP1594549B1 (en) Hypoxia inducible vegf plasmid for ischemic disease
RU2522810C1 (ru) Носитель для направленной доставки нуклеиновых кислот в клетки, экспрессирующие рецептор cxcr4
Hodish et al. Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TK
US20060193832A1 (en) Use of the sodium iodine symporter to effect uptake of iodine
Zhang et al. Cell-specific viral gene therapy of a Hurthle cell tumor
Bowles et al. Prospects for adenovirus-mediated gene therapy of inherited diseases of the myocardium
Lee et al. Usefulness of intra-arterial embolization method using gelfoam particles in effective gene transduction of adenoviral vector for liver-directed gene therapy: an preliminary animal study in dogs
EP1679375A1 (en) Methods and compositions for cancer therapies using genes encoding interferon-beta
MXPA00002101A (es) Metodos y composiciones para terapias que utilizan genes que codifican proteinas secretadas como beta-interferon